Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
Resource Type
Article
Authors
Simms-Williams, Nikita ; Treves, Nir ; Yin, Hui ; Lu, Sally ; Yu, Oriana ; Pradhan, Richeek ; Renoux, Christel ; Suissa, Samy ; Azoulay, Laurent
Source
BMJ: British Medical Journal; 5/4/2024, Vol. 385 Issue 8427, p1-13, 13p
Subject
CARDIOVASCULAR disease related mortality COMBINATION drug therapy GLUCAGON-like peptide-1 agonists PEOPLE with diabetes CARDIOVASCULAR diseases RESEARCH funding MAJOR adverse cardiovascular events CARDIOVASCULAR diseases risk factors HEART failure LONGITUDINAL method SODIUM-glucose cotransporter 2 inhibitors TYPE 2 diabetes COMPARATIVE studies CONFIDENCE intervals PSYCHOSOCIAL factors KIDNEYS PROPORTIONAL hazards models
Language
ISSN
17561833